ArticlePloS one2017

The novel phospholipid mimetic KPC34 is highly active against preclinical models of Philadelphia chromosome positive acute lymphoblastic leukemia.

Peter M Alexander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.